Suchergebnisse - "Criscitiello, C"

PubPharm (28)

1

How I treat HER2-positive early breast cancer : how long adjuvant trastuzumab is needed?

enthalten in: ESMO open | 2022

von Morganti, S. | Bianchini, G. | Giordano, A. | +3

2

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

3

Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis

enthalten in: Cancer treatment reviews | 2021

von Trapani, D. | Gandini, S. | Corti, C. | +6

4

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

5

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

6

Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer

enthalten in: ESMO open | 2021

von Corti, C. | Criscitiello, C.

7

Impact of COVID-19 on social media as perceived by the oncology community : results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network

enthalten in: ESMO open | 2021

von Morgan, G. | Tagliamento, M. | Lambertini, M. | +15

8

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

9

Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Criscitiello, C. | Vingiani, A. | Maisonneuve, P. | +3

10

Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Criscitiello, C. | Vingiani, A. | Maisonneuve, P. | +3